William K. Heiden
2013
In 2013, William K. Heiden earned a total compensation of $2.1M as Chief Executive Officer at AMAG Pharmaceuticals, a 46% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $370,800 |
|---|---|
| Option Awards | $724,592 |
| Salary | $512,116 |
| Stock Awards | $484,170 |
| Other | $7,650 |
| Total | $2,099,328 |
Heiden received $724.6K in option awards, accounting for 35% of the total pay in 2013.
Heiden also received $370.8K in non-equity incentive plan, $512.1K in salary, $484.2K in stock awards and $7.7K in other compensation.
Rankings
In 2013, William K. Heiden's compensation ranked 3,754th out of 12,286 executives tracked by ExecPay. In other words, Heiden earned more than 69.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,754 out of 12,286 | 69th |
Division Manufacturing | 1,274 out of 4,612 | 72nd |
Major group Chemicals And Allied Products | 346 out of 1,466 | 76th |
Industry group Drugs | 241 out of 1,160 | 79th |
Industry Pharmaceutical Preparations | 196 out of 890 | 78th |
Source: SEC filing on April 15, 2016.
Heiden's colleagues
We found five more compensation records of executives who worked with William K. Heiden at AMAG Pharmaceuticals in 2013.
2013
Greg Madison
AMAG Pharmaceuticals
Former Executive Vice President and Chief Commercial Officer
2013
Frank Thomas
AMAG Pharmaceuticals
Chief Operating Officer
2013
Christopher White
AMAG Pharmaceuticals
Senior Vice President and Chief Business Officer
2013
Scott Townsend
AMAG Pharmaceuticals
General Counsel
2013
Scott Holmes
AMAG Pharmaceuticals